Sunday, July 21, 2024

Bionano publicizes the Stratys™ system for OGM and VIA™ software program for hematologic malignancies

Bionano publicizes the Stratys™ system for OGM and VIA™ software program for hematologic malignancies

[ad_1]

Bionano Genomics, Inc. immediately introduced the Stratys system for top throughput optical genome mapping (OGM) and VIA software program for visualization, interpretation and reporting of genome evaluation for OGM, microarrays and next-generation sequencing (NGS) information in a single built-in software program platform. VIA additional incorporates these information into an intuitive and highly effective workflow for hematologic malignancies.

Bionano’s Stratys system for OGM presents elevated throughput capabilities to deal with the wants of mid and high-volume customers. The throughput of the Stratys instrument is as much as 4 instances better than that of Bionano’s Saphyr instrument, it’s suitable with the most recent G2 chemistry and has a possible sample-to-answer time of three days for hematological samples interrogated throughout the entire genome at excessive sensitivity to uncommon variants. The system is designed for optimum lab flexibility by enabling as much as 12 single entry chips, accessible as they full runs, with out the necessity to batch a number of samples on a consumable. Industrial rollout of the system will initially embrace 10 early entry websites who might be given the chance to undertake it as manufacturing capability is being expanded, with full capability anticipated by early 2024.

VIA software program replaces NxScientific software program with a easy and built-in workflow for visualization, interpretation and reporting for information varieties which can be normal throughout molecular pathology and cytogenomics: OGM, NGS and microarrays. The VIA software program is designed to automate variant calling, annotation and interpretation, for enhanced contextualization throughout a number of variant varieties and accelerated time to outcomes at a lowered value. This launch additionally presents a brand new hematologic malignancy workflow, together with curated assets that signify guideline-based targets relevant to hematological illness. A workflow targeted on genetic illness is anticipated later in 2023. VIA installations will start on the finish of July 2023.

We’re happy to announce two thrilling new merchandise that we imagine will speed up adoption of OGM by greater quantity customers and increase utilization: the Stratys system for OGM and our VIA software program with a workflow for hematologic malignancies. Stratys is the subsequent evolution within the OGM workflow and presents labs with excessive pattern volumes better pattern flexibility throughout a wide range of analysis purposes, with enhanced throughput and lowered sample-to-answer time. VIA replaces NxScientific with a platform that analyzes OGM information alongside different information varieties and creates a strong and environment friendly workflow for information from OGM, NGS and microarrays to be reported individually or built-in right into a single report back to contextualize all lessons of genomic variation and drive significant insights.”

Mark Oldakowski, Chief Working Officer, Bionano

Erik Holmlin, PhD, president and chief government officer of Bionano, commented, “These are the product launches we imagine will overcome limitations confronted by high-volume customers looking for to run OGM on a routine foundation in medical analysis – quicker information era and streamlined evaluation and reporting. The prowess of Stratys for OGM is unbelievable and the utility of VIA because the platform for visualization, interpretation and reporting of cytogenomic information goes effectively past simply OGM customers because it touches the NGS communities in most cancers and genetic illnesses.”

[ad_2]

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest Articles